November 18, 2016 - By Ellis Scott · 0 Comments
IRADIMED CORP (NASDAQ:IRMD) institutional sentiment increased to 1.86 in Q2 2016. Its up 0.73, from 1.13 in 2016Q1. The ratio increased, as 35 investment managers opened new or increased positions, while 31 cut down and sold their holdings in IRADIMED CORP. The investment managers in our partner’s database now hold: 2.15 million shares, down from 2.82 million shares in 2016Q1. Also, the number of investment managers holding IRADIMED CORP in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 15 Reduced: 16 Increased: 27 New Position: 8.
IRADIMED CORPORATION develops, makes, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The company has a market cap of $134.23 million. The Firm operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. It has a 16.46 P/E ratio. The Company’s MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous part and other features in order to deliver anesthesia and other IV fluids during various MRI procedures.
The stock closed at $11.25 during the last session. It is down 27.28% since April 18, 2016 and is downtrending. It has underperformed by 31.71% the S&P500.
According to Zacks Investment Research, “iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump modules; dose error reduction systems; Masimo SET SpO2 monitoring products; and MRI Pulse oximeters, and MRI oximeter remotes and displays under the iMagox name used during MRI procedures. iRadimed Corporation is headquartered in Winter Park, Florida.”
Jfs Wealth Advisors Llc holds 1.14% of its portfolio in Iradimed Corp for 190,000 shares. Awm Investment Company Inc. owns 158,830 shares or 0.74% of their US portfolio. Moreover, Timpani Capital Management Llc has 0.69% invested in the company for 74,936 shares. The Pennsylvania-based Conestoga Capital Advisors Llc has invested 0.46% in the stock. Ativo Capital Management Llc, a Illinois-based fund reported 57,347 shares.#img1#
Insider Transactions: Since January 1, 0001, the stock had 1 buy, and 4 selling transactions for $512,086 net activity.
Ratings analysis reveals 50% of iRadimed’s analysts are positive. Out of 2 Wall Street analysts rating iRadimed, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $25 while the high is $30. The stock’s average target of $27.50 is 144.44% above today’s ($11.25) share price. IRMD was included in 5 notes of analysts from July 30, 2015. The stock of Iradimed Corp (NASDAQ:IRMD) has “Buy” rating given on Monday, November 2 by TH Capital. Roth Capital maintained the stock with “Buy” rating in Monday, November 2 report. The stock of Iradimed Corp (NASDAQ:IRMD) has “Neutral” rating given on Wednesday, October 5 by Roth Capital. The stock of Iradimed Corp (NASDAQ:IRMD) earned “Buy” rating by Roth Capital on Monday, April 4. The firm earned “Buy” rating on Thursday, July 30 by TH Capital.
IRADIMED CORPORATION (IRADIMED), incorporated on April 8, 2014, develops, makes, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Firm operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. The Company’s MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous parts and other features in order to deliver anesthesia and other IV fluids during various MRI procedures. Each system consists of MRidium MRI compatible IV infusion pump, non-magnetic mobile stand and disposable IV tubing sets.
More notable recent Iradimed Corp (NASDAQ:IRMD) news were published by: Streetinsider.com which released: “Iradimed Corp. (IRMD) Tops Q3 EPS by 3c” on October 28, 2016, also Seekingalpha.com with their article: “iRadimed Corp. (IRMD) CEO Roger Susi on Q3 2016 Results – Earnings Call Transcript” published on October 29, 2016, Seekingalpha.com published: “IRadimed Corp. (IRMD) CEO Roger Susi on Q2 2016 Results – Earnings Call Transcript” on July 31, 2016. More interesting news about Iradimed Corp (NASDAQ:IRMD) were released by: Zacks.com and their article: “Should You Get Rid of IRadimed Corporation (IRMD) Now?” published on October 14, 2016 as well as Globenewswire.com‘s news article titled: “IRADIMED CORPORATION Announces Second Quarter 2016 Financial Results” with publication date: July 29, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Ellis Scott